Searchable abstracts of presentations at key conferences in endocrinology

ea0094p93 | Neuroendocrinology and Pituitary | SFEBES2023

The clinical course of pituitary metastases: illustrations from clinical cases

Shaikh Sheeba , Iqbal Zohaib , Garcez kate , Waddell Tom , Hoong Ho Jan , Adam Safwaan

Pituitary metastases are reportedly uncommon. Here we report two cases illustrating metastases responding to systemic anticancer therapy (SACT). A 49-year-old woman with metastatic renal cell carcinoma treated with combination ipilimumab and nivolumab immunotherapy was referred for hypocortisolaemia (morning cortisol 74 nmol/l). Biochemical screening revealed an adrenocorticotropic hormone of 16ng/l (0-46), thyroid-stimulating-hormone 0.1mU/l (0.55-4.78), free thyroxine 7 pmol...

ea0094p171 | Adrenal and Cardiovascular | SFEBES2023

A clinical case demonstrating the challenges in diagnosing and managing Paraneoplastic Cushing’s Syndrome

Iqbal Zohaib , Ho Jan , Walker Leanne , White Ann , Monaghan Philip , Thirkettle Sally , Gulamhusein Aziz , Keevil Brian , Mansoor Wasat , Adam Safwaan

We present a case of a 62-year-old lady with a grade 3 well-differentiated metastatic gastric-neuroendocrine tumour complicated by symptoms of CS (weight-gain, bruising, proximal weakness) which developed over 4 weeks. She had progressive disease after exhausting all conventional anti-neoplastic therapeutic options. Screening tests revealed raised 24-h urinary free cortisol (3460 nmol/24h[<165]), post-overnight dexamethasone suppression serum cortisol (serF) 1200 nmol/l(&#...

ea0077p61 | Metabolism, Obesity and Diabetes | SFEBES2021

The Effect of Bariatric Surgery on the proteome of people achieving remission of Type 2 Diabetes

Iqbal Zohaib , Fachim Helene , Gibson John , Baricevic-Jones Ivona , Campbell Amy , Geary Bethany , Donn Rachelle , Hamarashid Dashne , Syed Akheel , Whetton Anthony , Soran Handrean , Heald Adrian

Background: Bariatric surgery (BS) results in metabolic pathway recalibration. When major metabolic change occurs, blood protein components have a key role and can be altered significantly. We set out to identify potential biomarkers of change in plasma following BS in people achieving remission of type 2 diabetes mellitus (T2DM).Methods: Longitudinal analysis was performed on serum samples from 10 individuals who all achieved remission of T2DM following...

ea0077p173 | Metabolism, Obesity and Diabetes | SFEBES2021

Associations between reduction in body mass index (BMI) and proteins linked to neural function after 12 months of bariatric surgery

Fachim Helene , Iqbal Zohaib , Gibson Martin , Baracevic-Jones Ivonna , Campbel Amy , Geary Bethany , Donn Rachelle , Syed Akheel , Whetton Antony , Soran Handrean , Heald Adrian

Background: Bariatric surgery (BS) can have significant effects on multiple body systems and has been an effective intervention for morbid obesity, improving many comorbid medical conditions that are associated with mental health and cognitive dysfunction. It was previously shown that cognitive impairment was partly reversible in obese patients after BS [1], however, the effects of BS on proteins associated to central nervous system (CNS) still unknown. We evaluated if there a...

ea0077p192 | Metabolism, Obesity and Diabetes | SFEBES2021

N-acetylmuramoyl-L-alanine amidase is a biomarker for remission of type 2 diabetes after bariatric surgery

Iqbal Zohaib , Fachim Helene , Gibson John , Baricevic-Jones Ivona , Campbell Amy , Geary Bethany , Donn Rachelle , Syed Akheel , Wetton Anthony , Soran Handrean , Heald Adrian

Aims: We used sequential window acquisition of all theoretical fragment ion spectra Mass Spectrometry (SWATH-MS) to identify proteins acting as markers of remission of type 2 diabetes (T2DM) in patients who lost weight after bariatric surgery.Background: Bariatric surgery results in remission of T2DM in up to 80% of patients. The mechanisms underpinning are largely unknown. N-acetylmuramoyl-L-alanine amidase (PGLRYP2) is an immune response enzyme that br...